AUTHOR SUMMARY
The cardiac conduction system (CCS) controls the rhythmic contraction of the heart and consists of the sinoatrial node, atrioventricular (AV) node, AV bundle, bundle branches, and Purkinje fibers. These tissues initiate and propagate electrical depolarization to generate regular, synchronized chamber contractions required for normal cardiac function. The molecular and electrophysiological properties of CCS tissues are distinct from those of contractile myocardium, and individual CCS components have unique features that reflect their specialized function. The mechanisms regulating development, maturation, and maintenance of the conduction system are poorly understood. Irregular heart rhythms (i.e., arrhythmias) are primary indicators of CCS dysfunction. Only a few mutations in genes encoding molecules required for CCS function (i.e., ion channels or gap junction proteins) have been identified in humans with arrhythmias.
The protein TBX3 is critical for human development: mutations in TBX3 cause multiple anomalies in patients with ulnarmammary syndrome, including limb, dental, and genital malformations, and apocrine and mammary gland hypoplasia. Recent data from mice and humans also suggest roles for Tbx3 in CCS development however, embryonic lethality of mutant mice lacking functional Tbx3 has previously prevented testing whether, or in which tissues, Tbx3 is required for development or maintenance of CCS components. We created unique genetic and physiologic tools in mice to test the requirements for Tbx3 in these processes. Our study employs a complex allelic series that results in varying levels of Tbx3 gene function in mice, and reveals that development of the specialized structural and functional characteristics of the CCS is extremely sensitive to the dosage of Tbx3.
We also demonstrate an essential role of Tbx3 in adult CCS homeostasis.
We achieved graded increments in Tbx3 mRNA production in vivo by combining different unique Tbx3 hypomorphic alleles (reduced Tbx3 function), as well as tissue-specific and temporal conditional ablation mutants. Additionally, we developed powerful techniques for evaluating embryonic and fetal cardiac conduction in vivo, including direct ECG recordings ( Fig. P1 A-D) and noninvasive echocardiograms ( Fig. P1 E and  F) . Multiple arrhythmia types were identified in mutants bearing different allelic combinations ( Fig. P1 B-D and F) and lethal AV block (Fig. P1 D and  F) was observed in mutants with the lowest Tbx3 levels. Mutants with incremental increases in Tbx3 dosage survived to birth and adulthood; however, they exhibited multiple arrhythmias and sudden death. ECG findings were consistent with the arrhythmias detected by embryonic ECG (Fig. P1 D and F) .
Depletion or conditional disruption of Tbx3 in different regions of the developing heart causes discrete arrhythmia phenotypes: SAN pauses and bra- Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE24122). dycardia (i.e., slow heart rate, Fig. P1 B and C) indicate SAN dysfunction, whereas preexcitation (i.e., premature depolarization) and AV block reveal abnormalities in the AV junction. Arrhythmias in Tbx3 mutants are accompanied by disrupted expression of multiple ion channel genes, despite preserved expression of previously described CCS markers. Arrhythmias induced by conditional knockdown of Tbx3 in adults revealed that it is required for conduction system homeostasis. To our knowledge, these are the first investigations of arrhythmias caused by Tbx3 deficiency. We have discovered unique, nonredundant requirements for Tbx3 at multiple levels of the developing and mature CCS. Tbx3 is required for establishing and maintaining the correct molecular identity and functional properties of the conduction system in a highly dosage-sensitive manner. Our studies indicate that TBX3 and its regulatory targets merit investigation as candidates for human arrhythmias, and suggest that humans with TBX3 mutations and ulnar-mammary syndrome may benefit from ECG screening. The resolution of arrhythmias after Tbx3 conditional ablation in adult mice suggests that conduction tissue regenerates or reorganizes to compensate for abnormal function of Tbx3-depleted cells. The requirement for Tbx3 in adult CCS homeostasis suggests it may be a useful factor for conduction tissue regeneration efforts.
